GL1X · GenesisL1 explorer

Research workbench

Anti-blood group a fv

Analyse Anti-blood group a fv in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1JV5
Type
protein
Length
224 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ig kappa chain precursor V region; Ig chain heavy chain precursor V region
UniProt
P01594
Pockets
2 · best druggability 0.43

Structure

x-ray diffraction · 2 distinct chains · 4% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIg kappa chain precursor V regionprotein1073% helix, 49% strandP01594
BIg chain heavy chain precursor V regionprotein1175% helix, 52% strand—

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1720.430.8014empty
2740.310.7417empty

Interfaces

1 interface between chains.

  • A–B · 766 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 1JV5 · Anti-blood group A Fv · the same entry in another collection · chain A against A, TM-score 1.00
  • P01594 · AlphaFold monomer V2.0 prediction for immunoglobulin kappa variable 1-33 (P01594) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.